Update on the Episurf MTP implant – response to FDA submitted
Episurf Medical (NASDAQ: EPIS B) today announces that a response to the US FDA, addressing a request for additional information on the company’s Episealer® MTP implant, has been filed. This is a step in the process for the 510(k) submission for market clearance of the Episealer® MTP implant for the big toe. The FDA review has been on hold while waiting for Episurf to submit this additional information. “Getting us to this milestone is a great team effort and an important step in our work towards market clearance for Episealer® MTP. We have performed an extensive work together with
